Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Revenue (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Revenue for 17 consecutive years, with $12.5 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 1.3% to $12.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.2 billion through Dec 2025, changed 0.22% year-over-year, with the annual reading at $48.2 billion for FY2025, 0.22% changed from the prior year.
  • Revenue for Q4 2025 was $12.5 billion at Bristol Myers Squibb, up from $12.2 billion in the prior quarter.
  • The five-year high for Revenue was $12.5 billion in Q4 2025, with the low at $11.0 billion in Q3 2023.
  • Average Revenue over 5 years is $11.7 billion, with a median of $11.7 billion recorded in 2021.
  • The sharpest move saw Revenue increased 15.54% in 2021, then dropped 5.6% in 2025.
  • Over 5 years, Revenue stood at $12.0 billion in 2021, then fell by 4.83% to $11.4 billion in 2022, then grew by 0.62% to $11.5 billion in 2023, then grew by 7.54% to $12.3 billion in 2024, then grew by 1.3% to $12.5 billion in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $12.5 billion, $12.2 billion, and $12.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.